The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation

被引:472
作者
Lonard, DM [1 ]
Nawaz, Z [1 ]
Smith, CL [1 ]
O'Malley, BW [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S1097-2765(00)80259-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogen receptor-alpha (ER alpha) is downregulated in the presence of its cognate ligand, estradiol (E2), through the ubiquitin proteasome pathway. Here, we show that ubiquitin proteasome function is required for ER alpha to serve as a transcriptional activator. Deletion of the last 61 amino acids of ER alpha, including residues that form helix 12, abolishes ligand-mediated downregulation of the receptor as do point mutations in the ligand binding domain that impair coactivator binding. In addition, coactivators also are subject to degradation by the 26S proteasome, but their intrinsic transcriptional activity is not affected. These data provide evidence that protein interactions with ER alpha coactivator binding surfaces are important for ligand-mediated receptor downregulation and suggest that receptor and coactivator turnover contributes to ER alpha transcriptional activity.
引用
收藏
页码:939 / 948
页数:10
相关论文
共 66 条
  • [1] Proteasome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation
    Alarid, ET
    Bakopoulos, N
    Solodin, N
    [J]. MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) : 1522 - 1534
  • [2] ALLAN GF, 1992, J BIOL CHEM, V267, P19513
  • [3] The proteasome:: Paradigm of a self-compartmentalizing protease
    Baumeister, W
    Walz, J
    Zühl, F
    Seemuller, E
    [J]. CELL, 1998, 92 (03) : 367 - 380
  • [4] Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
    Baur, EV
    Zechel, C
    Heery, D
    Heine, MJS
    Garnier, JM
    Vivat, V
    LeDouarin, B
    Gronemeyer, H
    Chambon, P
    Losson, R
    [J]. EMBO JOURNAL, 1996, 15 (01) : 110 - 124
  • [5] TRANSCRIPTIONAL ACTIVATION BY THE ESTROGEN-RECEPTOR REQUIRES A CONFORMATIONAL CHANGE IN THE LIGAND-BINDING DOMAIN
    BEEKMAN, JM
    ALLAN, GF
    TSAI, SY
    TSAI, MJ
    OMALLEY, BW
    [J]. MOLECULAR ENDOCRINOLOGY, 1993, 7 (10) : 1266 - 1274
  • [6] Molecular basis of agonism and antagonism in the oestrogen receptor
    Brzozowski, AM
    Pike, ACW
    Dauter, Z
    Hubbard, RE
    Bonn, T
    Engstrom, O
    Ohman, L
    Greene, GL
    Gustafsson, JA
    Carlquist, M
    [J]. NATURE, 1997, 389 (6652) : 753 - 758
  • [7] DEGRADATION OF NUCLEAR ONCOPROTEINS BY THE UBIQUITIN SYSTEM INVITRO
    CIECHANOVER, A
    DIGIUSEPPE, JA
    BERCOVICH, B
    ORIAN, A
    RICHTER, JD
    SCHWARTZ, AL
    BRODEUR, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) : 139 - 143
  • [8] Structure and functions of the 20S and 26S proteasomes
    Coux, O
    Tanaka, K
    Goldberg, AL
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 : 801 - 847
  • [9] IDENTIFICATION OF A CONSERVED REGION REQUIRED FOR HORMONE DEPENDENT TRANSCRIPTIONAL ACTIVATION BY STEROID-HORMONE RECEPTORS
    DANIELIAN, PS
    WHITE, R
    LEES, JA
    PARKER, MG
    [J]. EMBO JOURNAL, 1992, 11 (03) : 1025 - 1033
  • [10] ESTROGEN-RECEPTOR SYNTHESIS AND TURNOVER IN MCF-7 BREAST-CANCER CELLS MEASURED BY A DENSITY SHIFT TECHNIQUE
    ECKERT, RL
    MULLICK, A
    RORKE, EA
    KATZENELLENBOGEN, BS
    [J]. ENDOCRINOLOGY, 1984, 114 (02) : 629 - 637